ARID1A and neoplasm: Loss of ARID1A leads to the accumulation of R‐loops, which generates cytoplasmic DNA that activates the STING‐I type interferon signalling pathway, inducing gene expression that promote anti‐tumour immunity, providing a theoretical basis for improving immune checkpoint blockade (ICB) therapy [53].